SICK and Endress+Hauser have announced a strategic partnership in process automation. SICK’s advanced gas analysis and flow measurement technology is now a part of Endress+Hauser’s instrumentation portfolio. In a press release on Jan. 7, Endress+Hauser Canada (E+H) said the collaboration aims to offer customers in the process industry enhanced support in increasing plant efficiency, protecting the environment and reducing carbon footprint.

As a result of the strategic partnership, around 800 sales and service employees from SICK will transfer to Endress+Hauser across 42 countries. According to E+H, the collaboration in process automation will allow customers to access a broader range of products from a single source and benefit from enhanced expertise in gas measurement technology. With its global sales network, Endress+Hauser will access new customers, reach additional industries and tap into further application areas.

The production and further development of the gas analyzers and flowmeters were brought together under the umbrella of Endress+Hauser SICK GmbH+Co. KG. SICK and Endress+Hauser will each hold 50 percent of the joint venture as of 1 March 2025. The company employs around 730 people at several German sites and will collaborate closely with Endress+Hauser’s product centers to drive product innovation and meet evolving market demands.

“This partnership is a perfect match,” said Dr Peter Selders, CEO of the Endress+Hauser Group. “It creates new opportunities for growth and development, particularly in the sustainable transformation of the process industry. By joining forces, we offer added value to our customers. Our combined efforts will make us faster and ultimately more successful than if we acted alone. In this case, one and one equals more than two.”

“We are pleased that the strategic partnership for process automation is now starting. Together, we can better support customers worldwide and guide them into a sustainable future with leading technological solutions. We are convinced that the transformation of the process industry offers enormous opportunities for growth and development, which we will optimally leverage as strong partners,” said Dr Mats G?kstorp, chairman of the executive board of SICK AG.